Protara Therapeutics, Inc. logo

Protara Therapeutics, Inc.

NASDAQ:TARA

Overview | Financials
Company Name Protara Therapeutics, Inc.
Symbol TARA
Currency USD
Price 1.92
Market Cap 39,609,216
Dividend Yield 0%
52-week-range 1.04 - 5.24
Industry Biotechnology
Sector Healthcare
CEO Mr. Jesse Shefferman
Website https://www.protaratx.com

An error occurred while fetching data.

About Protara Therapeutics, Inc.

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement

Related Stocks

Psychemedics Corporation logo

Psychemedics Corporation

PMD

2.33 USD

Regulus Therapeutics Inc. logo

Regulus Therapeutics Inc.

RGLS

1.62 USD

Microbot Medical Inc. logo

Microbot Medical Inc.

MBOT

0.925 USD

Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH

9.05 USD

Check-Cap Ltd. logo

Check-Cap Ltd.

CHEK

1.73 USD

Financials

Numbers are in millions USD

Numbers are in millions USD